Exhaled Nitric Oxide

Immunology and Allergy Clinics of North America

Volumn 27, Issue 4, 2007, Pages 571-586

  Stewart, Lora ^a   Katial, Rohit ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUTICASONE; GLUCOCORTICOID; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOXIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STEROID;

AIRFLOW; ASTHMA; BRONCHIOLITIS OBLITERANS; CHEMICAL ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CILIARY DYSKINESIA; CLINICAL TRIAL; CYSTIC FIBROSIS; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INTERSTITIAL LUNG DISEASE; LIPID PEROXIDATION; LUNG FUNCTION TEST; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW;

ADRENAL CORTEX HORMONES; ASTHMA; BREATH TESTS; BRONCHIOLITIS OBLITERANS; CYSTIC FIBROSIS; EOSINOPHILIA; HUMANS; KARTAGENER SYNDROME; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES;

EID: 35748971067     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.09.002     Document Type: Review

References (92)

1. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
2. Gustafsson L.E., Leone A.M., Persson M.G., et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 181 (1991) 852-857
3. Alving K., Weitzberg E., and Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6 (1993) 1368-1370
4. Kharitonov S.A., Yates D., Robbins R.A., et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343 (1994) 133-135
5. Persson M.G., Zetterstrom O., Agrenius V., et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 343 (1994) 146-147
6. Yates D.H., Kharitonov S.A., Robbins R.A., et al. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 152 (1995) 892-896
7. Kharitonov S.A., Yates D.H., and Barnes P.J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 153 (1996) 454-457
8. Massaro A.F., Gaston B., Kita D., et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 152 (1995) 800-803
9. Ignarro L.J., Buga G.M., Wood K.S., et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84 (1987) 9265-9269
10. Kerwin J.F., and Heller M. The arginine-nitric oxide pathway: a target for new drugs. Med Res Rev 14 (1994) 23-74
11. Moncada S., and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
12. Silkoff P., Lent A., Busacker A., et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 116 (2005) 1249-1255
13. Gaston B., Kobzik L., and Stamler J.S. Distribution of nitric oxide synthase in the lung. In: Zapol W.M., and Bloch K.D. (Eds). Nitric oxide and the lung (1997), Dekker, New York 75-86
14. Ricciardolo F.L., Sterk P.J., Gaston B., et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev 84 (2004) 731-765
15. Förstermann U., Schmidt H.H., Pollock J.S., et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 42 (1991) 1849-1857
16. Guo F.H., De Raeve H.R., Rice T.W., et al. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A 92 (1995) 7809-7813
17. Fischer A., Folkerts G., Geppetti P., et al. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 15 (2002) 73-81
18. Yates D.H. Role of exhaled nitric oxide in asthma. Immunol Cell Biol 79 (2001) 178-190
19. Belvisi M.G., Stretton C.D., Yacoub M., et al. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 210 (1992) 221-222
20. Li C.G., and Rand M.J. Evidence that part of the NANC relaxant response of guinea pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 102 (1991) 91-94
21. Shaul P.W., North A.J., Wu L.C., et al. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest 94 (1994) 2231-2236
22. Pechkovsky D.V., Zissel G., Goldmann T., et al. Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II. Am J Physiol Lung Cell Mol Physiol 282 (2002) L684-L692
23. Li D., Shirakami G., Zhan X., et al. Regulation of ciliary beat frequency by the nitric oxide cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol 23 (2000) 175-181
24. Getsberg I., Hellman V., Fainshtein M., et al. Intracellular Ca2+ regulates the phosphorylation and the dephosphorylation of ciliary proteins via the NO pathway. J Gen pHsiol 124 (2004) 527-540
25. Jain B., Rubinstein I., Robbins R.A., et al. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 191 (1993) 83-88
26. Di Rosa M., Radomski M., Carnuccio R., et al. Glucocorticosteroids inhibit the expression of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 172 (1990) 1246-1252
27. Radomski M.W., Palmer R.M.J., and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 87 (1990) 10043-10047
28. Bove P.F., and Van der Vliet A. Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic Biol Med 41 (2006) 515-527
29. Silkoff P.E., McClean P.A., Slutsky A.S., et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 155 (1997) 260-267
30. Silkoff P.E., Sylvester J.T., Zamel N., et al. Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 161 (2000) 1218-1228
31. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171 (2005) 912-930
32. George S.C., Hogman M., Permutt S., et al. Modeling pulmonary nitric oxide exchange. J Appl Physiol 96 (2004) 831-839
33. Tsoukias N.M., and George S.C. A two-compartment model of pulmonary nitric oxide exchange dynamics. [see comment]. J Appl Physiol 85 (1998) 653-666
34. Paraskakis E., Brindicci C., Fleming L., et al. Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med 174 (2006) 260-267
35. Lehtimaki L., Kankaanranta H., Saarelainen S., et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 163 (2001) 1557-1561
36. Olivieri M., Talamini G., Corradi M., et al. Reference values for exhaled nitric oxide (reveno) study. Respir Res 7 (2006) 94
37. Olin A.C., Alving K., and Toren K. Exhaled nitric oxide: relation to sensitization and respiratory symptoms. Clin Exp Allergy 34 (2004) 221-226
38. Buchvald F., Baraldi E., Carraro S., et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 115 (2005) 1130-1136
39. Olin A.C., Rosengren A., Thelle D.S., et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 130 5 (2006) 1319-1325
40. Berlyne G.S., Parameswaran K., Kamada D., et al. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 106 (2000) 638-644
41. Jatakanon A., Lim S., Kharitonov S.A., et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53 (1998) 91-95
42. Warke T.J., Fitch P.S., Brown V., et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 57 (2002) 383-387
43. Brightling C.E., Symon F.A., Birring S.S., et al. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 58 (2003) 528-532
44. Payne D.N., Adcock I.M., Wilson N.M., et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. [see comment]. Am J Respir Crit Care Med 164 (2001) 1376-1381
45. van den Toorn L.M., Overbeek S.E., de Jongste J.C., et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 164 (2001) 2107-2113 [Published erratum appears in Am J Respir Crit Care Med 2002, 166:1143]
46. Little S.A., Chalmers G.W., MacLeod K.J., et al. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 55 (2000) 232-234
47. Smith A.D., Cowan J.O., Brassett K.P., et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 172 (2005) 453-459
48. Szefler S.J., Phillips B.R., Martinez F.D., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. [see comment]. J Allergy Clin Immunol 115 (2005) 233-242
49. Pijnenburg M.W., Bakker E.M., Hop W.C., et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 172 (2005) 831-836
50. Katsara M., Donnelly D., Iqbal S., et al. Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children. Respir Med 100 (2006) 1512-1517
51. Franklin P.J., Taplin R., and Stick S.M. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 159 (1999) 69-73
52. Kissoon N., Duckworth L.J., Blake K.V., et al. Exhaled nitric oxide concentrations: online versus offline values in healthy children. Pediatr Pulmonol 33 (2002) 283-292
53. Tsang K.W., Ip S.K., Leung R., et al. Exhaled nitric oxide: the effects of age, gender and body size. Lung 179 (2001) 83-91
54. Chambers D.C., Tunnicliffe W.S., and Ayres J.G. Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax 53 (1998) 677-679
55. Horvath I., Donnelly L.E., Kiss A., et al. Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers. Respiration 71 (2004) 463-468
56. Sont J.K., Han J., van Krieken J.M., et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51 (1996) 496-502
57. Dupont L.J., Demedts M.G., and Verleden G.M. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 123 (2003) 751-756
58. Smith A.D., Cowan J.O., Filsell S., et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 169 (2004) 473-478
59. Smith A.D., and Taylor D.R. Is exhaled nitric oxide measurement a useful clinical test in asthma?. Curr Opin Allergy Clin Immunol 5 (2005) 49-56
60. Zietkowski Z., Bodzenta-Lukaszyk A., Tomasiak M.M., et al. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients. J Investig Allergol Clin Immunol 16 (2006) 239-246
61. Delgado-Corcoran C., Kissoon N., Murphy S.P., et al. Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 5 (2004) 48-52
62. Jatakanon A., Lim S., and Barnes P.J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 161 (2000) 64-72
63. Sont J.K., Willems L.N., Bel E.H., et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159 (1999) 1043-1051
64. Green R.H., Brightling C.E., Woltmann G., et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57 (2002) 875-879
65. Meyts I., Proesmans M., and De Boeck K. Exhaled nitric oxide corresponds with office evaluation of asthma control. Pediatr Pulmonol 36 (2003) 283-289
66. Smith A.D., Cowan J.O., Brassett K.P., et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173
67. Robbins R.A., Floreani A.A., Von Essen S.G., et al. Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med 153 (1996) 1631-1635
68. Corradi M., Majori M., Cacciani G.C., et al. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 54 (1999) 572-575
69. Bhowmilk A., Seemungal T.A.R., Donaldson G.C., et al. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur Respir J 26 (2005) 1009-1015
70. Maziak W., Loukides S., Culpitt S., et al. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 998-1002
71. Rutgers S.R., van der Mark T.W., Coers W., et al. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax 54 (1999) 576-580
72. Jeffrey P.K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53 (1998) 129-136
73. Ansarin K., Chatkin J.M., Ferreira I.M., et al. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur Respir J 17 (2001) 934-938
74. Pedoto A., Caruso J.E., Nandi J., et al. Acidosis stimulates nitric oxide production and lung damage in rats. Am J Respir Crit Care Med 159 (1999) 397-402
75. Elphick H.E., Demoncheaux E.A.G., Ritson S., et al. Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax 56 (2001) 151-152
76. Franklin P.J., Hall G.L., Moeller A., et al. Exhaled nitric oxide is not reduced in infants with cystic fibrosis. Eur Respir J 27 (2006) 350-353
77. Grasemann H., Michler E., Wallot M., et al. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24 (1997) 173-177
78. Keen C., Olin A.C., Edenoft A., et al. Airway nitric oxide in patient with cystic fibrosis is associated with pancreatic function, pseudomonas infection, and polyunsaturated fatty acids. Chest 131 (2007) 1857-1864
79. Lundberg J.O.N., Nordvall S.L., Weitzberg E., et al. Exhaled NO in pediatric asthma and cystic fibrosis. Arch Dis Child 75 (1996) 323-326
80. Thomas S.R., Kharitonov S.A., Scott S.F., et al. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 117 (2000) 1085-1089
81. Armstrong D.S., Grimwood K., Carlin J.B., et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 156 (1997) 1197-1204
82. Grasemann H., Knauer N., Busher R., et al. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 162 (2000) 2172-2176
83. Tiev K.P., Cabane J., Aubourg F., et al. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide. Eur Respir J 30 (2007) 26-30
84. Wilsher M.L., Fergusson W., Milne D., et al. Exhaled nitric oxide in sarcoidosis. Thorax 60 (2005) 967-970
85. Narang I., Ersu R., Wilson N.M., et al. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 57 (2002) 586-589
86. Horvath I., Loukides S., Wodehouse T., et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 58 (2003) 68-72
87. Zihlif N., Paraskakis E., Lex C., et al. Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia. Pediatr Pulmonol 39 (2005) 551-557
88. Loukides S., Kharitonov S.A., Wodehouse T., et al. Effect of L-arginine on mucociliary function in primary ciliary dyskinesia. Lancet 352 (1998) 371-372
89. Kharitonov S.A., Lubec G., Lubec B., et al. L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 88 (1995) 135-139
90. Sundaresan S., Trulock E.P., Mohanakumar T., et al. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg 60 (1995) 1341-1346
91. Heng D., Sharples L.D., McNeil K., et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis and risk factors. J Heart Lung Transplant 17 (1998) 1255-1263
92. Brugiere O., Thabut G., Mal H., et al. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome. Eur Respir J 25 (2005) 813-819